Login

Switch On Your HIV Smarts.

Author Archives: Liz Highleyman

Simpler HIV treatment, with only 2 drugs, keeps viral loads suppressed

Simpler HIV treatment, with only 2 drugs, keeps viral loads suppressed

, by Liz Highleyman

People taking only two drugs, dolutegravir and rilpivirine, maintained viral suppression in participants of the SWORD-1 an SWORD-2 studies. Read More

Timothy Brown, the Berlin Patient, Celebrates a Decade Cured of HIV

Timothy Brown, the Berlin Patient, Celebrates a Decade Cured of HIV

, by Liz Highleyman

The only person cured of HIV, Brown now takes Truvada as PrEP to prevent a new HIV infection. Read More

High sexually transmitted infection rates spur condom debate

High sexually transmitted infection rates spur condom debate

, by Liz Highleyman

What’s causing the rising STI rates? And, do rising STI rates mean that we should be promoting condom use for everyone? Read More

For people with drug resistant HIV, monoclonal antibody shows promise as “rescue” therapy

For people with drug resistant HIV, monoclonal antibody shows promise as “rescue” therapy

, by Liz Highleyman

A monoclonal antibody shows promise for people living with HIV who are “left behind,” with few HIV treatment options, when current antiretrovirals fail from drug resistance. Read More

Can a Two-Drug Treatment Regimen Keep HIV Under Control?

Can a Two-Drug Treatment Regimen Keep HIV Under Control?

, by Liz Highleyman

HIV therapy with two drugs, instead of three, kept 90% of people undetectable in a small proof-of-concept study. Read More